Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Divalproex bulk supplier for pharma manufacturers

Divalproex 50 mg, 500 mg Suppliers & Bulk Manufacturers

Available Forms: Extended-Release Tablets

Available Strengths: 50 mg, 500 mg

Reference Brands: Depakote ER®(US)

Category: Antipsychotropic Drugs

Divalproex Extended-Release (Depakote ER) is a CNS medication used for epilepsy, bipolar disorder, and migraines. Available in 250 mg and 500 mg tablets in the US and EU, it supports once-daily dosing. A strategic neurotherapy product for B2B sourcing with global demand and regulatory compliance.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Divalproex Extended-Release (ER) is a widely prescribed anticonvulsant and mood stabilizer used to treat epilepsy, bipolar disorder, and migraine prophylaxis. This formulation ensures sustained drug release, offering once-daily dosing and improved patient compliance. Marketed in the US under Depakote ER and available across the EU in multiple generic and branded forms, Divalproex ER is manufactured in strengths of 250 mg and 500 mg. Its versatility in neuropsychiatric and neurological conditions makes it a key product for global pharmaceutical sourcing. Ideal for B2B buyers looking to expand in CNS therapeutics, Divalproex ER meets stringent regulatory and quality standards.

Divalproex — third party manufacturing & bulk supply

Divalproex 50 mg, 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Indicative minimum order quantity

Divalproex is supplied as Extended-Release Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Divalproex listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Divalproex →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Divalproex is listed as Extended-Release Tablets in 50 mg, 500 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Divalproex is referenced against Depakote ER®(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Divalproex is catalogued under Antipsychotropic Drugs on PharmaTradz. Related products within the same category are listed at the foot of this page.

Submit an RFQ stating your destination market, required quantity and whether you need stock supply, third party manufacturing or dossier licensing. Matched suppliers respond with pricing, MOQ and lead times.

Related Products

Lithium Carbonate

Strength:
150 mg, 300 mg, 600 mg

Form: Tablets

Reference Brands: Lithobid (USA/LATAM), Priadel (EU)

View Details
Thiothixene

Strength:
2 mg, 5 mg, 10 mg

Form: Capsules

Reference Brands: Navane (USA)

View Details
Solriamfetol

Strength:
75 mg, 150 mg

Form: Tablets

Reference Brands: Sunosi (USA/EU)

View Details
Phenobarbital Sodium

Strength:
65 mg/mL, 130 mg/mL.

Form: Injection

Reference Brands: Generic formulations marketed under different names

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.